Skip to content

Expo™ H74908526401Recalls & reported problems

Boston Scientific Corporation · Angiographic Catheter · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729366713), received between May 27, 2020 and Jan 27, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Patient Involvement1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THERE WAS A THROMBUS PRESENT. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS BEING PERFORMED. A WATCHMAN FXD CURVE ACCESS SYSTEM (WAS) AND A 24MM WATCHMAN FLX PRO LAA CLOSURE DEVICE & DELIVERY SYSTEM (WDS) WERE SELECTED TO BE USED. 10,00 UNITS OF HEPARIN WAS GIVEN PRIOR TO THE TRANSEPTAL PUNCTURE. THE TRANSSEPTAL PUNCTURE WAS THEN COMPLETED AND THE PHYSICIAN POSITIONED THE WAS IN THE LAA OF THE PATIENT. A SECOND DOSE OF 10,000 UNITS OF HEPARIN WAS GIVEN AFTER THE TRANSSEPTAL PUNCTURE. THE WDS WAS PREPARED, AND THE EXPO PIGTAIL CATHETER WAS REMOVED BUT CAME OUT WITH A THROMBUS PRESENT. THE PHYSICIAN REMOVED THE WAS AND ALL PRODUCTS FROM THE PATIENT. AN ADDITIONAL 10,000 UNITS OF HEPARIN WAS GIVEN TO THE PATIENT, AND THE PROCEDURE WAS CONTINUED WITH ALL NEW PRODUCTS. THE PROCEDURE WAS COMPLETED WITH THE CLOSURE DEVICE IMPLANTED IN THE LAA OF THE PATIENT. THE PATIENT DID NOT EXPERIENCE ANY COMPLICATIONS AS A RESULT OF THIS EVENT. THE PATIENT WILL BE OBSERVED FOR SIX (6) HOURS POST PROCEDURE AND THEN BE DISCHARGED HOME.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 21242082 ↗
  • MalfunctionMay 27, 2020Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    IT WAS REPORTED THAT FOREIGN MATERIAL WAS OBSERVED A MODEL 5F WAS PREPPED FOR USE TO VIEW THE TARGET LESION. PHYSICIAN NOTICED CATHETER HAD A PLASTIC PIECE ADHERED TO THE HUB. THEY WERE UNABLE TO USE IT. IT DID NOT GO INTO THE BODY, AND NO HARM WAS DONE TO THE PATIENT.

    Patient problems: No Patient Involvement

    MAUDE report 10092175 ↗

Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices

All CATHETER, INTRAVASCULAR, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page